Identification of a novel Ras-regulated proapoptotic pathway

Current Biology

Volumn 12, Issue 4, 2002, Pages 253-265

  Khokhlatchev, Andrei ^a   Rabizadeh, Shahrooz ^a   Xavier, Ramnik ^a   Nedwidek, Maria ^a   Chen, Tao ^a   Zhang, Xian Feng ^a   Seed, Brian ^a   Avruch, Joseph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELMINTH PROTEIN; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; PEPTIDE; PROTEIN SERINE THREONINE KINASE; RAS PROTEIN; RASSF1 PROTEIN, HUMAN; RASSF5 PROTEIN, HUMAN; STK4 PROTEIN, HUMAN; STK4 PROTEIN, MOUSE; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; CAENORHABDITIS ELEGANS; CELL MEMBRANE; CELL STRAIN 3T3; CELL STRAIN COS1; CHEMISTRY; GENETICS; HUMAN; IMMUNOBLOTTING; LEUKEMIA CELL LINE; MACROMOLECULE; METABOLISM; MOUSE; PROTEIN BINDING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

3T3 CELLS; ANIMALS; APOPTOSIS; CAENORHABDITIS ELEGANS; CELL MEMBRANE; COS CELLS; GENES, TUMOR SUPPRESSOR; HELMINTH PROTEINS; HUMANS; IMMUNOBLOTTING; JURKAT CELLS; MACROMOLECULAR SUBSTANCES; MICE; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM PROTEINS; PEPTIDES; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RAS PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0037133034     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(02)00683-8     Document Type: Article

References (56)

1. Understanding Ras: "It ain't over 'til it's over"
2. The effector interactions of p21 ras
3. Ras activation of the Raf kinase: Tyrosine kinase recruitment of the MAP kinase cascade
4. Ras oncogenes in human cancer: A review
5. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells
6. Multiple Ras functions can contribute to mammalian cell transformation
7. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS
8. Cell cycle-dependent activation of Ras
9. Activation of phosphatide 3-kinase by interaction with Ras and by point mutation
10. Ras caught in another affair; the exchange factors for Ral
11. Identification of AF-6 and canoe as putative targets for Ras
12. A human protein selected for interference with Ras functions interacts directly with Ras and competes with Raf
13. Identification of NORE1 as a potential Ras effector
14. Fibroblast immortality is a prerequisite for transformation by EJ C-Ha-ras oncogene
15. Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene
16. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation
17. Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation
18. Ras versus cyclin-dependent kinase inhibitors
19. INK4a
20. Ras signaling and apoptosis
21. Integration of positive and negative growth signals during ras pathway activation in vivo
22. p19 ARF links the tumour suppressor p53 to Ras
23. ARF links the tumour suppressors RB and p53
24. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability
25. Requirement of NFκ-B activation to suppress p53-independent apoptosis induced by oncogene Ras
26. Suppression of Ras-induced apoptosis by the Rac GTPase
27. Oncogenic Ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species
28. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes
29. Epigenetic inactivation of a Ras association domain family protein from the lung tumour suppressor locus 3p21.3
30. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression
31. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers
32. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis
33. The putative tumor supressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein, Nore1
34. Cloning and characterization of a human protein kinase with homology to Ste20
35. Newly identified stress-responsive protein kinases, Krs-1 and Krs-2
36. The Ste20 group kinases as regulators of MAP kinase cascades
37. Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like MST1
38. Proteolytic activation of MST1/Krs, STE20-related protein kinase by caspase during apoptosis
39. Both phosphorylation and Caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/Fas-induced apoptosis
40. Analysis of function and regulation of proteins that mediate signal transduction by use of lipid-modified plasma membrane-targeting sequences
41. The importance of being K-Ras
42. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase
43. Oncogenic Ras-mediated cell growth arrest and apoptosis are associated with increased ubiquitin-dependent cyclin D1 degradation
44. Four human Ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility
45. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events
46. Ras signaling in tumor necrosis factor-induced apoptosis
47. Proliferative inhibition by dominant-negative Ras rescues naive and neuronally differentiated PC12 cells from apoptotic death
48. Ras activation leads to cell proliferation or apoptotic cell death upon interleukin-2 stimulation or lymphokine deprivation, respectively
49. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis
50. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor
51. A novel assay to measure loss of plasma membrane asymmetry during apoptosis in adherent cells in culture
52. Isolation, characterization and localization of annexin V from chicken liver
53. Flow cytometry of apoptotic cell death
54. Neurotrophin dependence mediated by p75 NTR: Contrast between rescue by BDNF and NGF
55. An alternative, nonapoptotic form of programmed cell death